- Drug Pipelines
- February 2024
- 144 Pages
Global
From €7156EUR$7,950USD£6,130GBP
- Report
- April 2022
- 37 Pages
Global
From €1800EUR$2,000USD£1,542GBP
- Report
- June 2025
- 50 Pages
Global
From €2385EUR$2,650USD£2,043GBP
Metopimazine is a type of gastrointestinal drug used to treat nausea and vomiting. It is a dopamine antagonist, meaning it works by blocking the action of dopamine, a chemical messenger in the brain that can cause nausea and vomiting. Metopimazine is available in both oral and injectable forms, and is often used in combination with other antiemetic drugs. It is commonly prescribed for the treatment of nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery. It is also used to treat motion sickness, vertigo, and other conditions.
Metopimazine is available in generic and brand-name formulations, and is sold by a variety of pharmaceutical companies. Some of the companies that produce metopimazine include Pfizer, Novartis, Sanofi, Merck, and GlaxoSmithKline. Show Less Read more